Acquisitions Increase Growth Outlook
(in U.S. dollars unless otherwise noted)
TORONTO, Aug. 9, 2025 /PRNewswire/ - "I am very pleased with our record financial results this...
AARHUS, Denmark, Aug. 7, 2025 /PRNewswire/ -- Stibo Systems, a global master data management (MDM) solutions provider, has deepened its strategic collaboration with Microsoft,...
PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing all resources toward AI,...
PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing all resources toward AI,...
MUMBAI, India, Aug. 6, 2025 /PRNewswire/ -- Dun & Bradstreet India, a leading provider of business decisioning data and analytics, proudly celebrates its 30th anniversary—marking three...
Tokyo, Japan and Cambridge, UK, 6 August 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces the launch of a broad new pipeline strategically focused on advancing next-generation therapies for obesity and associated metabolic disorders.
The TYK2 inhibitor market is expected to witness substantial growth in the coming years, driven by the increasing prevalence of autoimmune diseases, robust clinical...
ATLANTA, Aug. 5, 2025 /PRNewswire/ -- VPN.com officially announces that MarketCap.com, one of the most sought-after domain names in the financial and crypto industries,...
Allows Performance Tuning Designs of AI Clusters to Specialized Workloads
TAIPEI, Aug. 5, 2025 /PRNewswire/ -- Today, the Open Compute Project Foundation (OCP), the nonprofit...
VANCOUVER, BC, Aug. 1, 2025 /PRNewswire/ - Kootenay Silver Inc. (TSXV: KTN) (OTCQX: KOOYF) (the "Company" or "Kootenay") is pleased to announce the filing...
VedTechBio enhances RxAgentAI platform; teams with US-based AlphaMeld to cut drug discovery time and co-develop therapies for rare and metabolic diseases.